Our mission is to accelerate deep in-vivo insights into human biology and enable researchers to develop and deliver solutions that improve human health
An expert in CRISPR genome editing, InVivo Biosystems creates custom genome-edited C. elegans and zebrafish models to enable aging, developmental and disease studies. Our unique living platforms and technologies bridge the gap between cells and mice, providing faster, cost-effective investigations that focus on proof-of-principle experiments for rapid go/no-go decision making and advance the discovery and early-stage development of new compounds.
InVivo Biosystems provides essential services to help pharmaceutical, nutraceutical, biotechnology companies and academic research institutions around the globe accelerate their research and drug development efforts.
An expert in CRISPR genome editing, InVivo Biosystems creates custom genome-edited C. elegans and zebrafish models to enable aging, developmental and disease studies. Our unique living platforms and technologies bridge the gap between cells and mice, providing faster, cost-effective investigations that focus on proof-of-principle experiments for rapid go/no-go decision making and advance the discovery and early-stage development of new compounds.
InVivo Biosystems provides essential services to help pharmaceutical, nutraceutical, biotechnology companies and academic research institutions around the globe accelerate their research and drug development efforts.
Location: United States, Oregon, Eugene
Employees: 11-50
Phone: +1 844-663-8749
Founded date: 2011
Founders name: Ari Gargir
Founders Related Locations: United States, Oregon, Eugene
Investors 1
| Date | Name | Website |
| - | Cascade Se... | cascadesee... |
Persons 1
| Date | First Name | Last Name | Title | |||
| - | Ari | Gargir | CEO &a... | linkedin.c... | - | - |
Mentions in press and media 7
| Date | Title | Description |
| 04.02.2025 | InVivo Biosystems Welcomes Biotech Veteran Brian A. Pollok to Board of Directors | InVivo Biosystems InVivo Biosystems, a leader in preclinical development and genome editing, announces the appointment of Brian Pollok, Ph.D., to its Board of Directors. InVivo Biosystems is strongly positioned to transform preclinical rese... |
| 13.08.2024 | InVivo Biosystems Announces Groundbreaking Innovation in Preclinical Development | InVivo Biosystems unveils MIC-Drop, a cutting-edge multiplex CRISPR gene editing technology MIC-Drop revolutionizes genetic research by allowing multiple CRISPR edits in one step, accelerating preclinical and rare disease breakthroughs.” — ... |
| 25.06.2024 | InVivo Biosystems Unveils New Leadership Team to Drive Next Phase of Innovation and Growth | InVivo Biosystems announces newly appointed Chief Scientific Officer and Vice President of Strategic Partnerships. Our new leadership team's collective expertise and shared passion for innovation will drive us to create impactful solutions ... |
| 11.04.2024 | InVivo Biosystems Announces New CEO | Kathryn McCormick Appointed CEO, Succeeding Matthew Beaudet EUGENE, OREGON, UNITED STATES, April 11, 2024 /EINPresswire.com/ -- InVivo Biosystems, experts in CRISPR-edited animals for biomedical discovery, announced today that the InVivo Bi... |
| 31.08.2022 | InVivo Biosystems and Thaena Announce Novel Metabolite Research Platform With Compelling Longevity and Healthspan Implications and Outcomes | “We are investigating a novel approach to looking at the metabolites or postbiotics that the human microbiota produces. The mixture surprised us when it significantly extended lifespan and healthspan,” said Andrea McBeth, co-founder of Thae... |
| 15.06.2021 | InVivo Biosystems Launches New Formulation Analysis Platform to Aid Anti-Ageing Product Research and Development | The new Platform helps companies prioritize development pipelines by giving them actionable, quantitative information about how candidate formulations combat ageing and age-related conditions. - Matt Beaudet, CEO, InVivo Biosystems EUGENE, ... |
| - | InVivo Biosystems | “Preclinical CRO provides custom analytical services using CRISPR genome edited zebrafish and C. elegans models to enable aging and rare genetic diseases research and reduce cost and time in drug discovery.” |